E. Pérez

发表

A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study

A. Segura‐Carretero, S. Verdura, E. Cuyás, 2018, Oncotarget.

Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative

X. Castells, H. Schünemann, A. Torresin, 2021, British Journal of Cancer.